Depreciation of Enliven Therapeutics, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Enliven Therapeutics, Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Enliven Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2025 was $74,000, a 6.3% decline year-over-year.
  • Enliven Therapeutics, Inc. annual Depreciation for 2025 was $263,000, a 17% decline from 2024.
  • Enliven Therapeutics, Inc. annual Depreciation for 2024 was $317,000, a 6.7% increase from 2023.
  • Enliven Therapeutics, Inc. annual Depreciation for 2023 was $297,000, a 38% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Enliven Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $263,000 -$54,000 -17% 01 Jan 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
2024 $317,000 +$20,000 +6.7% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
2023 $297,000 +$82,000 +38% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $215,000 +$100,000 +87% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $115,000 +$18,000 +19% 01 Jan 2021 31 Dec 2021 8-K 23 Jun 2023
2020 $97,000 +$64,000 +194% 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2022 2021 FY
2019 $33,000 01 Jan 2019 31 Dec 2019 10-K 05 Mar 2021 2020 FY

Enliven Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $74,000 -$5,000 -6.3% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $79,000 +$12,000 +18% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $67,000 +$28,000 +72% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q1 2022 $39,000 +$14,000 +56% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $25,000 +$1,000 +4.2% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q1 2020 $24,000 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.